Febri Sugiokto, PhD

  • Postdoctoral Research Fellow, UT Health San Antonio

Why did you choose the University of Pittsburgh?

University of Pittsburgh has been known as top-rank research university, especially in microbiology and immunology field.

Education & Training

  • PhD in Microbiology and Immunology, University of Pittsburgh School of Medicine, 2026
  • MS in Microbiology and Immunology, Tzu Chi University (Taiwan), 2020
  • BS in Biotechnology, Atma Jaya Catholic University (Indonesia), 2015

Research Interests

Cancer Virology

Publications

Sugiokto FG, Li R. 2024. Targeted eradication of EBV-positive cancer cells by CRISPR/dCas9-mediated EBV reactivation in combination with ganciclovir. mBio.15(7), e00795-24


Sugiokto FG, Saiada F, Zhang K, and Li R. 2024. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.  mBio. 15(2), e03168-23


Zhang K, Zhang Y, Maharjan Y, Sugiokto FG, Wan J, Li R. 2021. Caspases Switch off the m6A RNA Modification Pathway to Foster the Replication of a Ubiquitous Human Tumor Virus. mBio 12(4), e01706-21


Shahed-Al-Mahmud M, Roy R, Sugiokto FG, Islam MN, Lin MD, Lin LC, Lin NT. 2021. Phage phiAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofim Formation and Infection. Antibiotics 10 (3), 279


Yulandi A, Sugiokto FG, Febrilina, Suwanto A. 2016. Genomic Sequence of Klebsiella pneumoniae IIEMP-3, a Vitamin B12-Producing Strain from Indonesian Tempeh. Genome Announcements 4(1), e01724-15.